Auxilium On a Roll ...
Health Care: Drugs
Biocryst Pharmaceuticals (BCRX: NASDAQ)
$3.11 0.19 | 6.51%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 19.64M | 62.38M | 74.59M | 56.56M |
| Cost of Sales | -1.24M | -2.18M | 2.93M | -1.63M |
| Gross Operating Profit | 20.88M | 64.56M | 71.66M | 58.19M |
| Selling, General, and Administrative Expenses | 12.33M | 14.18M | 11.48M | 10.40M |
| Research & Development | 56.90M | 82.47M | 72.30M | 73.33M |
| Operating Income before D & A (EBITDA) | -48.34M | -32.09M | -12.12M | -25.54M |
| Depreciation & Amortization | 1.24M | 2.27M | 1.61M | 1.63M |
| Interest Income | 413.00K | 503.54K | 285.69K | 2.43M |
| Other Income - Net | -4.00M | 0.00 | 0.00 | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -53.17M | -33.85M | -13.45M | -24.73M |
| Interest Expense | 3.77M | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | -56.95M | -33.85M | -13.45M | -24.73M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -56.95M | -33.85M | -13.45M | -24.73M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -56.95M | -33.85M | -13.45M | -24.73M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -56.95M | -33.85M | -13.45M | -24.73M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-56.95M | -33.85M | -13.45M | -24.73M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -56.95M | -33.85M | -13.45M | -24.73M |
| Basic EPS from Continuing Ops. | -1.26 | -0.76 | -0.35 | -0.65 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -1.26 | -0.76 | -0.35 | -0.65 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -1.26 | -0.76 | -0.35 | -0.65 |
| Basic Normalized Net Income/Share | -1.26 | -0.76 | -0.35 | -0.65 |
| EPS fr Continuing Ops. | -1.26 | -0.76 | -0.35 | -0.65 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -1.26 | -0.76 | -0.35 | -0.65 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -1.26 | -0.76 | -0.35 | -0.65 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-1.26 | -0.76 | -0.35 | -0.65 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with BCRX
- Portfolio NameUser Type
- ContributorUnder-$10 Setting Up To Tra...
- Usertech
- Userrio grande
- UserDebbie0913 Portfolio 1
- UserPART 7 JPMorgan 28th Annual...
- UserSolana Partners
- UserLatest 2009
- ContributorFast Money's 3 Buys & 4...
- User10 shots
- ContributorCramer's Healthcare Stock Buys
Latest BCRX Headlines from TheStreet
- Hot Biotech Stocks Traded by Hedge Funds in First Quarter 05.16.12 | 07:05 am
- Biotech Stock Mailbag: Vivus, Chelsea, BioCryst 02.17.12 | 05:02 am
- 5 Under-$10 Stocks Set to Soar 12.29.11 | 06:12 pm
- Biocryst's Gout Drug Fails to Impress 10.05.11 | 11:10 am
- Dendreon's Blowup Spreads Across Biotech 08.04.11 | 10:08 am
- Biotech Stock Mailbag: Vivus 09.24.10 | 07:09 am
- BioCryst Tripped Up by Downgrade 09.23.10 | 04:09 pm
- Savient: Drug Approval or Another Delay? 09.10.10 | 08:09 am
- Biotech Calendar: Key Dates for September 09.01.10 | 07:09 am
- BioCryst Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript 04.28.10 | 06:04 pm
Press Releases for BCRX
- BioCryst To Present At Two Upcoming Investor Conferences - Business Wire 05.22.12 | 06:05 am
- BioCryst Provides Corporate Update And Reports First Quarter 2012 Financial Results - Business Wire 05.07.12 | 06:05 am
- BioCryst To Report First Quarter 2012 Financial Results On May 7, 2012 - Business Wire 04.25.12 | 06:04 am
- BioCryst To Present At Two Upcoming Investor Conferences - Business Wire 02.23.12 | 06:02 am
- BioCryst Reports Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.16.12 | 06:02 am
- BioCryst Announces Promising Results From Preclinical Studies Of BCX5191 For Hepatitis C - Business Wire 02.15.12 | 06:02 am
- BioCryst To Announce Fourth Quarter And Full Year 2011 Financial Results On February 16, 2012 - Business Wire 02.06.12 | 06:02 am
- Nancy Hutson Appointed To BioCryst’s Board Of Directors - Business Wire 01.19.12 | 06:01 am
- BioCryst Announces Positive Results From Its Ongoing BCX4208 Phase 2B Study In Patients With Gout - Business Wire 01.08.12 | 05:01 pm
- BioCryst Pharmaceuticals Presents New BCX4208 Gout Data At The 2011 ACR/ARHP Annual Scientific Meeting - Business Wire 11.08.11 | 06:11 am
Partner Headlines for BCRX
- Today's Market News To Trade On: 5 Stocks Making News - Seeking Alpha 03.23.12 | 08:03 am
- UPDATE: Bird Flu Found in the Netherlands - Benzinga 03.19.12 | 01:03 pm
- Noteworthy Institutional 5% Ownership Filings Last Week - Seeking Alpha 03.19.12 | 09:03 am
- Oink Oink: Profit From The Return Of Swine Flu - Benzinga 01.12.12 | 01:01 pm
- Biotechs And Their Trials By Fire - Seeking Alpha 11.07.11 | 09:11 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 11.04.11 | 09:11 am
- BioCryst Pharmaceuticals To Present New Peramivir Data at the 51st Annual ICAAC Meeting - Benzinga 09.17.11 | 06:09 pm
- A Bullish Speculative Options Bet and a Bearish One - Seeking Alpha 06.30.11 | 09:06 am
- 7 Speculative Healthcare Stocks to Rejuvenate Your Portfolio - Seeking Alpha 05.31.11 | 08:05 am
- UPDATE 1-BioCryst says influenza drug lowers virus concentration - Reuters 01.13.11 | 08:01 am
